What We Do

We employ advanced mathematical and computational methods to develop powerful 3D simulation engines for in silico experiments of targeted anticancer drug therapeutics using a variety of nanoparticle delivery mechanisms.

We specialise in the development of cutting-edge algorithms for simulation of cancer dynamics that execute on a real-time supercomputing and parallel processing platform. Our virtual Spartacus NanoLab™ offers a full range of 3D interactive experiments and computational simulations through our proprietary software and innovative technology.

Developed within a professionally engineered architecture, the Spartacus NanoLab™ offers clients a feature rich and fully dynamic virtual cancer laboratory. Our focus is on providing a full range of interactive in silico user-driven test beds and realistic 3D simulation environments using cutting-edge advancements in GPU-accelerated computing, computational fluid dynamics and nanotechnology.

Company Updates


Algenet has begun preliminary talks with a top UK university hospital to trial its ground-breaking 3D mammography technology aimed at better detection and diagnosis of early stage breast cancer. Watch for updates in 2017!


Read the technical series 'Spotlight' available online now!


New Science Frontier article

The development of a new matrix operator could have interesting applications in quantum physics.


New research paper published in International Journal of Applied Mathematics and Theoretical Physics

Extending the 4 × 4 Darbyshire Operator Using n-Dimensional Dirac Matrices.


New Science Frontier article

New computational methods for simulating nanoparticle dynamics for targeted anticancer drug therapeutics.


New research paper published in Cancer Research Journal

Dynamics of Magnetic Nanoparticles in Newly Formed Microvascular Networks Surrounding Solid Tumours: A Parallel Programming Approach.


New Science Frontier article

Innovative advances in parallel computing open up the possibilities of virtual cancer experiments in 3D.


New Science Frontier article

Developments in parallel processing are paving the way for in silico experiments to take up the challenge of aiding in a cure for cancer outside of the laboratory.

Global News


Long-term treatment with Olaparib can maintain quality of life and stop cancer progressing

AstraZeneca has today reported that the drug Olaparib (Lynparza) can be used as part of a maintenance programme to ensure women maintain their quality of life, with few side effects, throughout their treatment.


New tumor-shrinking nanoparticle to fight cancer, prevent recurrence

A research team has developed a new type of cancer-fighting nanoparticle aimed at shrinking breast cancer tumors, while also preventing recurrence of the disease.


Every child with cancer to have tumour DNA sequenced to find best treatment

Every child with cancer in Britain will have their tumour DNA sequenced so they can get the best possible drugs and help the UK catch up with treatment in Europe and the US.


3D colour x-ray that can zoom in on tumours will 'revolutionise' cancer treatment

The American Association for the Advancement of Science was told of the British developed tool x-CSI, which is described as 'low-dose, high-resolution, non-invasive and specific'.


Skin cancer breakthrough 2017: Melanoma spread reduced by up To 90% with new man-made compound

Skin cancer is the most common form of cancer is the world, and although melanoma is a more rare form, it is also the most deadly. New research from Michigan State University may soon change this.


NHS cancer testing service 'at breaking point'

Tests for cancer diagnosis are under threat as labs struggle to cope with rising demand, a charity says.


Breast cancer: The first sign is not always a lump

Around 1 in 6 women eventually diagnosed with breast cancer initially go to their doctors with a symptom other than a lump, according to a new study.